Cargando…

COVID-19 vaccine deliberation among people who inject drugs

BACKGROUND: People who inject drugs (PWID) are at greater risk for severe morbidity and mortality associated with COVID-19 due to comorbid, chronic, medical conditions and structural inequities associated with housing instability and incarceration. As such, they are a population that would greatly b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cioffi, Camille C, Kosty, Derek, Nachbar, Sarah, Capron, Christopher G, Mauricio, Anne Marie, Tavalire, Hannah F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942572/
https://www.ncbi.nlm.nih.gov/pubmed/35345466
http://dx.doi.org/10.1016/j.dadr.2022.100046
_version_ 1784673332075954176
author Cioffi, Camille C
Kosty, Derek
Nachbar, Sarah
Capron, Christopher G
Mauricio, Anne Marie
Tavalire, Hannah F
author_facet Cioffi, Camille C
Kosty, Derek
Nachbar, Sarah
Capron, Christopher G
Mauricio, Anne Marie
Tavalire, Hannah F
author_sort Cioffi, Camille C
collection PubMed
description BACKGROUND: People who inject drugs (PWID) are at greater risk for severe morbidity and mortality associated with COVID-19 due to comorbid, chronic, medical conditions and structural inequities associated with housing instability and incarceration. As such, they are a population that would greatly benefit from COVID-19 vaccination. METHODS: We surveyed 350 syringe exchange clients between March 2021 and June 2021 to collect information on vaccine uptake among PWID, facilitators and barriers to vaccination, and demographic correlates of vaccine hesitancy. RESULTS: Findings highlight that among PWID, vaccination access was remarkably low with only 10% of the sample receiving a COVID-19 vaccine. Vaccine acceptability among people who were unvaccinated was 42% highlighting barriers to access. Motivation for vaccination included a desire to keep family members and other community members safe and a desire to feel safe around other people. Barriers to vaccination included concerns about vaccine side effects, lack of concern surrounding the effects of COVID-19, and insufficient information about how the vaccine works, along with general distrust of the vaccine development and deployment process. CONCLUSIONS: There is a need for structural interventions and individual behavioral interventions to improve COVID-19 vaccine access and uptake among PWID. Limitations and implications for next steps and future directions are discussed.
format Online
Article
Text
id pubmed-8942572
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89425722022-03-24 COVID-19 vaccine deliberation among people who inject drugs Cioffi, Camille C Kosty, Derek Nachbar, Sarah Capron, Christopher G Mauricio, Anne Marie Tavalire, Hannah F Drug Alcohol Depend Rep Full Length Report BACKGROUND: People who inject drugs (PWID) are at greater risk for severe morbidity and mortality associated with COVID-19 due to comorbid, chronic, medical conditions and structural inequities associated with housing instability and incarceration. As such, they are a population that would greatly benefit from COVID-19 vaccination. METHODS: We surveyed 350 syringe exchange clients between March 2021 and June 2021 to collect information on vaccine uptake among PWID, facilitators and barriers to vaccination, and demographic correlates of vaccine hesitancy. RESULTS: Findings highlight that among PWID, vaccination access was remarkably low with only 10% of the sample receiving a COVID-19 vaccine. Vaccine acceptability among people who were unvaccinated was 42% highlighting barriers to access. Motivation for vaccination included a desire to keep family members and other community members safe and a desire to feel safe around other people. Barriers to vaccination included concerns about vaccine side effects, lack of concern surrounding the effects of COVID-19, and insufficient information about how the vaccine works, along with general distrust of the vaccine development and deployment process. CONCLUSIONS: There is a need for structural interventions and individual behavioral interventions to improve COVID-19 vaccine access and uptake among PWID. Limitations and implications for next steps and future directions are discussed. Elsevier 2022-03-24 /pmc/articles/PMC8942572/ /pubmed/35345466 http://dx.doi.org/10.1016/j.dadr.2022.100046 Text en © 2022 The Author(s). Published by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Report
Cioffi, Camille C
Kosty, Derek
Nachbar, Sarah
Capron, Christopher G
Mauricio, Anne Marie
Tavalire, Hannah F
COVID-19 vaccine deliberation among people who inject drugs
title COVID-19 vaccine deliberation among people who inject drugs
title_full COVID-19 vaccine deliberation among people who inject drugs
title_fullStr COVID-19 vaccine deliberation among people who inject drugs
title_full_unstemmed COVID-19 vaccine deliberation among people who inject drugs
title_short COVID-19 vaccine deliberation among people who inject drugs
title_sort covid-19 vaccine deliberation among people who inject drugs
topic Full Length Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942572/
https://www.ncbi.nlm.nih.gov/pubmed/35345466
http://dx.doi.org/10.1016/j.dadr.2022.100046
work_keys_str_mv AT ciofficamillec covid19vaccinedeliberationamongpeoplewhoinjectdrugs
AT kostyderek covid19vaccinedeliberationamongpeoplewhoinjectdrugs
AT nachbarsarah covid19vaccinedeliberationamongpeoplewhoinjectdrugs
AT capronchristopherg covid19vaccinedeliberationamongpeoplewhoinjectdrugs
AT mauricioannemarie covid19vaccinedeliberationamongpeoplewhoinjectdrugs
AT tavalirehannahf covid19vaccinedeliberationamongpeoplewhoinjectdrugs